Evidence map›Paper›PMID 41080398›Full record

ArticleCureus2025

Palindromic Minocycline-Induced Vasculitis With Dual-Positivity for Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody (MPO-ANCA) and Anti-DNA Antibody.

Hiroto Tomoda, Yoshitaka Ueda

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hiroto TomodaDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, JPN.
Yoshitaka UedaDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term usage of minocycline can result in the development of various autoimmune conditions, including vasculitis. We herein report the case of a 23-year-old female patient who developed fever, arthralgia, and erythema of the lower limbs 15 months after the initiation of minocycline. Her symptoms recovered spontaneously within one and a half months but relapsed two months later along with dysesthesia of the lower limbs. Her myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) and anti-DNA antibody were positive, and histology of her skin demonstrated features of necrotizing vasculitis of the small vessels. Minocycline was discontinued, and her symptoms improved without requiring further treatment, along with the normalization of MPO-ANCA and anti-DNA antibody titers. No recurrence was observed nine months after discontinuation, although her lower limb dysesthesia lasted for six months before recovery. Clinicians should bear in mind the possibility of minocycline-induced vasculitis when symptoms of vasculitis are suspected in patients receiving long-term minocycline. An immediate withdrawal of the drug is recommended in such cases to prevent the development of organ-threatening lesions and long-lasting aftereffects.

Indexed as

anca-associated vasculitisdrug-induced vasculitisminocyclinempo-ancavasculitis

Identifiers

PMID41080398
PMCPMC12514459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.